We are live on ! Find out more
BAMCO Inc

BAMCO Inc Portfolio holdings

AUM $66.6B
1-Year Est. Return 7.35%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$66.6B
AUM Growth
+$33.5B
Cap. Flow
+$30.9B
Cap. Flow %
46.41%
Top 10 Hldgs %
60.87%
Holding
379
New
53
Increased
117
Reduced
155
Closed
34

Top Buys

Rank Stock Value
1
SPCX
SpaceX
SPCX
+$24.8B
2
SHOP icon
Shopify
SHOP
+$735M
3
SPOT icon
Spotify
SPOT
+$531M
4
MORN icon
Morningstar
MORN
+$476M
5
VRSK icon
Verisk Analytics
VRSK
+$386M

Top Sells

Rank Stock Value
1
WYNN icon
Wynn Resorts
WYNN
+$108M
2
ACGL icon
Arch Capital
ACGL
+$79M
3
FND icon
Floor & Decor
FND
+$64.4M
4
VRT icon
Vertiv
VRT
+$63.9M
5
LGN
Legence Corp
LGN
+$62.8M

Sector Composition

Rank Sector Weight
1 Industrials 43.36%
2 Consumer Discretionary 21.22%
3 Financials 12.91%
4 Technology 10.91%
5 Healthcare 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
276
Guardant Health
GH
$21.7B
$2.48M ﹤0.01%
16,500
-15,500
-48% -$1.69M
AMAT icon
277
Applied Materials
AMAT
$366B
$2.45M ﹤0.01%
+3,392
New +$1.57M
MDGL icon
278
Madrigal Pharmaceuticals
MDGL
$12.3B
$2.42M ﹤0.01%
4,500
-800
-15% -$410K
RVMD icon
279
Revolution Medicines
RVMD
$44.6B
$2.34M ﹤0.01%
12,500
+10,000
+400% +$1.46M
BAC icon
280
Bank of America
BAC
$436B
$2.34M ﹤0.01%
40,994
+12,794
+45% +$680K
KYMR icon
281
Kymera Therapeutics
KYMR
$9.82B
$2.29M ﹤0.01%
20,000
GILD icon
282
Gilead Sciences
GILD
$181B
$2.27M ﹤0.01%
18,000
-12,000
-40% -$1.58M
WH icon
283
Wyndham Hotels & Resorts
WH
$5.64B
$2.19M ﹤0.01%
+25,964
New +$2.15M
BE icon
284
Bloom Energy
BE
$62.1B
$2.18M ﹤0.01%
+7,204
New +$1.85M
MS icon
285
Morgan Stanley
MS
$337B
$2.01M ﹤0.01%
9,620
+520
+6% +$103K
PTGX icon
286
Protagonist Therapeutics
PTGX
$9.34B
$1.96M ﹤0.01%
16,000
+1,000
+7% +$104K
ELV icon
287
Elevance Health
ELV
$85.5B
$1.93M ﹤0.01%
+5,000
New +$1.85M
AEM icon
288
Agnico Eagle Mines
AEM
$104B
$1.88M ﹤0.01%
12,129
-1,238
-9% -$229K
DB icon
289
Deutsche Bank
DB
$75.8B
$1.74M ﹤0.01%
51,421
-88,276
-63% -$2.86M
JPM icon
290
JPMorgan Chase
JPM
$951B
$1.73M ﹤0.01%
+5,300
New +$1.65M
XENE icon
291
Xenon Pharmaceuticals
XENE
$5.81B
$1.51M ﹤0.01%
25,000
DEI icon
292
Douglas Emmett
DEI
$1.97B
$1.47M ﹤0.01%
124,363
ODD icon
293
ODDITY Tech
ODD
$662M
$1.35M ﹤0.01%
89,307
+26,677
+43% +$357K
BLK icon
294
Blackrock
BLK
$180B
$1.3M ﹤0.01%
1,352
+242
+22% +$250K
COF icon
295
Capital One
COF
$132B
$1.19M ﹤0.01%
5,919
-81
-1% -$15.5K
IONS icon
296
Ionis Pharmaceuticals
IONS
$10.1B
$1.11M ﹤0.01%
14,000
-31,000
-69% -$2.33M
INSM icon
297
Insmed
INSM
$25.9B
$1.07M ﹤0.01%
10,000
-10,000
-50% -$1.21M
AXP icon
298
American Express
AXP
$225B
$913K ﹤0.01%
+2,700
New +$864K
SCCO icon
299
Southern Copper
SCCO
$177B
$907K ﹤0.01%
+5,265
New +$946K
AER icon
300
AerCap
AER
$23.2B
$904K ﹤0.01%
+6,200
New +$881K

Similar funds

BAMCO Inc's Q2 2026 Portfolio in Review

As of Q2 2026, BAMCO Inc held 379 positions worth $66.6B, up 101% from $33.1B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

BAMCO Inc deployed $30.9B of net new capital in Q2 2026, opening 53 new positions and adding to 117 existing holdings. Its largest new stake was SpaceX: 145,775,147 shares worth $24.9B.

By sector, the portfolio is most concentrated in Industrials at 43% of assets, up from 8.6% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Wynn Resorts, an estimated $108M trimmed.

  • BAMCO Inc's largest Q2 2026 buy was SpaceX: 145,775,147 shares worth $24.9B.
  • BAMCO Inc added most to Shopify in Q2 2026, an estimated $735M increase.
  • BAMCO Inc's biggest Q2 2026 reduction was Wynn Resorts, cutting an estimated $108M.
  • BAMCO Inc fully exited Badger Meter in Q2 2026, selling an estimated $47.6M.
  • BAMCO Inc's ten largest holdings make up 61% of its $66.6B portfolio in Q2 2026.
  • BAMCO Inc opened 53 new positions and closed 34 in Q2 2026.
  • BAMCO Inc's portfolio value rose 101% quarter-over-quarter to $66.6B.

Based on BAMCO Inc's 13F filing for Q2 2026, filed 14 Aug 2026.